Intravaginal 6.5 mg prasterone administration in postmenopausal women with overactive bladder syndrome: A pilot study-Reference-Cited by-同舟云学术

Intravaginal 6.5 mg prasterone administration in postmenopausal women with overactive bladder syndrome: A pilot study

Published:2021-08 Issue: Volume:263 Page:67-71
ISSN:0301-2115
Container-title:European Journal of Obstetrics & Gynecology and Reproductive Biology
language:en
Short-container-title:European Journal of Obstetrics & Gynecology and Reproductive Biology

Author:

Matarazzo Maria Grazia,Sarpietro Giuseppe,Fiorito Debora^ORCID,Di Pasqua Salvatore,Ingrassano Simona,Panella Marco Marzio,Cianci Antonio,Caruso Salvatore^ORCID

Funder

Università degli Studi di Catania

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference45 articles.

1. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction;Haylen;Int Urogynecol J,2010

2. Prevalence and burden of overactive bladder in the United States;Stewart;World J Urol,2003

3. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society;Portman;Menopause,2014

4. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society, Menopause: September 2020 - Volume 27 - Issue 9 - p 976-992

5. Latthe P, Middleton L, Rachaneni S et al. On behalf of the BUS Collaborative Group. Ultrasound bladder wall thickness and detrusor overactivity: a multicentre test accuracy study. 2017 Royal College of Obstetricians and Gynaecologists.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormonal Medications for Genitourinary Syndrome of Menopause;Clinical Obstetrics & Gynecology;2023-11-21

2. Natural products for the treatment of urinary incontinence;Continence;2023-09

3. Nonestrogen Therapies for Treatment of Genitourinary Syndrome of Menopause;Obstetrics & Gynecology;2023-08-04

4. Treating and Managing Urinary Incontinence: Evolving and Potential Multicomponent Medical and Lifestyle Interventions;Research and Reports in Urology;2023-06

5. TOT in combination with solifenacin or intravaginal prasterone in postmenopausal women with mixed urinary incontinence: A retrospective analysis in 112 patients;LUTS: Lower Urinary Tract Symptoms;2023-03-04